View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

DOJ/DEA RIN: 1117-AA61 Publication ID: Spring 2022 
Title: Electronic Prescriptions for Controlled Substances 

By this final rule, the Drug Enforcement Administration (DEA) would finalize its regulations to clarify: (1) the criteria by which DEA-registered practitioners may electronically issue controlled substance prescriptions; and (2) the criteria by which DEA-registered pharmacies may receive and archive these electronic prescriptions. The finalized rule would contain modifications from the interim-final rule previously published. The final regulations would modify the requirements that must be met by any registrant who wishes to dispense controlled substances pursuant to electronic prescriptions, including requirements pertaining to authorized software applications. (The final rule would maintain the discretionary usage of electronic prescriptions found in the interim final rule.)

Agency: Department of Justice(DOJ)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1300    21 CFR 1304    21 CFR 1306    21 CFR 1311   
Legal Authority: 21 U.S.C. 802    21 U.S.C. 821    21 U.S.C. 827    21 U.S.C. 829    21 U.S.C. 871(b)   
Legal Deadline:  None
Action Date FR Cite
ANPRM  03/05/2001  66 FR 13274   
NPRM  06/27/2008  73 FR 36722   
NPRM Comment Period End  09/25/2008    
Interim Final Rule  03/31/2010  75 FR 16236   
Interim Final Rule Comment Period End  06/01/2010    
Interim Final Rule Effective  06/01/2010    
Interim Final Rule Comment Period Reopened  04/21/2020  85 FR 22018   
Interim Final Rule Comment Period End  06/22/2020  85 FR 22018   
Final Action  12/00/2022 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: Businesses  Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL:   Public Comment URL:  
RIN Data Printed in the FR: No 
Agency Contact:
Scott A. Brinks
Section Chief, Regulatory Drafting and Support Section, Diversion Control Division
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:571 362-8209